Forget Password?
  1. Indices
  2. Commodities
  3. Currencies
Straits Times 3,134.71 +18.54 +0.59%
Hang Seng 26,664.28 +160.35 +0.61%
Dow Jones 27,001.98 -22.82 -0.08%
Shanghai Composite 2,978.71 -12.33 -0.41%
The Trendlines Group Extents Incubator Franchise, Invests In 2 Medical Companies
Daily Bulletin | 17 December 2015
Related stocks:

The Trendlines Group has received formal notice of the renewal of its incubator franchise for a period of 8 years from 2016 to 2023 from the Office of the Chief Scientist of the Israel Ministry of Economy (OCS). Under the new terms, OCS will provide the group with an NIS4.94 million ($1.8 million) operating grant over the life of the franchise and the group is required to spend at least NIS10.08 million ($3.94 million) on the operation of the Incubator over the eight year period.

Separately, the group has also announced that it has, via Trendlines Medical – Misgav, established two new portfolio medical companies, namely Tandem Technologies, where the group has a 48.8 percent stake, as well as Zeev Implants, where the group has a 49.8 percent stake. Subsequently, the number of the group’s portfolio companies has increased to 47.

The Trendlines Group  0.089 -- --   
Business: Co incubates and develops technology-based companies in the medical and agricultural fields, based in Israel.

Insight: May-19, 1Q19 total income tripled to US$1.4m mainl... Read More

Join The Conversation
The Shares Investment editorial team welcomes constructive feedback on our coverage and content. We would also be delighted to answer any questions on the above article. Leave us a comment below, and we'll get back to you shortly!

All Rights Reserved. Pioneers & Leaders (Publishers) Pte Ltd. Best viewed with Mozilla Firefox 3.5 and above.